Isocural

Isotretinoin, the active ingredient in Isocural, is a retinoid presented as an oral capsule for oral use. It targets severe recalcitrant nodular acne, a form of acne vulgaris that persists despite standard topical and systemic treatments, and is prescribed for patients requiring intensive therapy.

GNH USA supplies Isocural as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring that each batch meets EU quality standards and is delivered with appropriate documentation for regulatory compliance and safety.

Isocural (isotretinoin) is used within the retinoid class to treat severe forms of acne vulgaris. - Severe recalcitrant nodular acne: reduces existing inflammatory lesions and prevents formation of new nodules. - Cystic acne: decreases cyst size and number, improving skin appearance. - Severe acne vulgaris: lowers overall lesion count and sebum production when other therapies have failed.

Isocural may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry skin and lips: increased xerosis and cheilitis. - Elevated liver enzymes: mild transaminase rise. - Hypertriglyceridemia: rise in blood triglyceride levels. - Photosensitivity: heightened skin reaction to sunlight.

Serious or Rare Side Effects: - Severe depression or mood changes: potential psychiatric effects. - Inflammatory bowel disease: onset or worsening of Crohn’s or ulcerative colitis. - Pancreatitis: acute inflammation of the pancreas. - Teratogenicity: risk of birth defects if exposure occurs during pregnancy.

When prescribing Isocural, clinicians should observe several precautionary measures to minimize risk. - Pregnancy contraindication: avoid use in women who are pregnant or may become pregnant. - Teratogenic risk: require effective contraception for both sexes during treatment and for one month after discontinuation. - Liver monitoring: check hepatic function tests before and periodically during therapy. - Lipid monitoring: assess serum triglycerides and cholesterol at baseline and during treatment. - Vitamin A intake: discourage concurrent high‑dose vitamin A supplements. - Store below 25°C: keep in the original container, protect from moisture and light.

Isocural can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Tetracycline antibiotics: increased intracranial pressure risk. - Vitamin A supplements: additive teratogenicity and toxicity. - Systemic retinoids: cumulative toxicity and severe mucocutaneous effects. - St. John’s wort: reduced isotretinoin plasma concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduced effectiveness, monitor for breakthrough bleeding. - Corticosteroids: enhanced risk of mood alterations. - Anticoagulants: potential alteration of INR, monitor coagulation parameters.